Clinical Trial Update: Ciprofloxacin for the Prevention of Postoperative Endoscopic Recurrence in Crohn's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial results in Crohn's disease evaluating ciprofloxacin to prevent postoperative endoscopic recurrence after surgery, with the study completed and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Ciprofloxacin (Ciprofloxacin hydrochloride)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED | Results posted: 2013-05-03